Type 2 diabetes remission and complication research

Research into type 2 diabetes has focused on the mechanisms of remission and the associated risks of long-term complications. Remission is defined as maintaining an A1c level below 6.5% for at least three consecutive months without the use of hypoglycemic medications. This state is primarily driven by significant weight loss and the reduction of visceral fat, which can be achieved through low-calorie diets, bariatric surgery, or new-generation medications like semaglutide.

Recent studies have identified specific clinical pathways and risks. The RESET for Remission trial found that a combination of supervised exercise and a low-calorie meal-replacement diet resulted in a 54% remission rate at 24 weeks.

Additionally, data from the University of Glasgow indicates that newly diagnosed patients face significant risks regarding organ health. Within five years of diagnosis, 19% of patients developed chronic kidney disease before heart failure. There is a notable correlation between these conditions, as 22.7% of those with kidney disease subsequently developed heart failure, while 42% of those with heart failure developed chronic kidney disease within five years.